Disruptive biomedical technology is bringing drastic changes to eye treatment. Opharmic applies its patented innovative ultra-sound technology to administer eye drugs in a non-invasive way. It negates the need for risky injections into the eyeball. The business matching support from HKSTP was instrumental for this breakthrough technology to gain traction.

 

Tags:
arrow up arrow down arrow left arrow right icon close icon text icon help icon hkstp